Drugs Made In America Acquisition Corp. 10-K Cybersecurity GRC - 2025-03-31

Page last updated on March 31, 2025

Drugs Made In America Acquisition Corp. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-31 16:05:46 EDT.

Filings

10-K filed on 2025-03-31

Drugs Made In America Acquisition Corp. filed a 10-K at 2025-03-31 16:05:46 EDT
Accession Number: 0001213900-25-026240

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY. We are a special purpose acquisition company with no business operations. Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our IPO.

Company Information